Woodline Partners LP Celldex Therapeutics, Inc. Transaction History
Woodline Partners LP
- $9.97 Billion
- Q2 2024
A detailed history of Woodline Partners LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 757,771 shares of CLDX stock, worth $24.9 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
757,771
Previous 751,060
0.89%
Holding current value
$24.9 Million
Previous $31.5 Million
11.03%
% of portfolio
0.28%
Previous 0.3%
Shares
9 transactions
Others Institutions Holding CLDX
# of Institutions
195Shares Held
63.4MCall Options Held
206KPut Options Held
176K-
Wellington Management Group LLP Boston, MA8.08MShares$265 Million0.05% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$154 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$123 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.39MShares$111 Million9.76% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$109 Million2.17% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.54B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...